| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9661 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.6277 |
| P-glycoprotein Substrate | Substrate | 0.6003 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6878 |
| Inhibitor | 0.5998 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6111 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6400 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7579 |
| CYP450 2D6 Substrate | Non-substrate | 0.6135 |
| CYP450 3A4 Substrate | Non-substrate | 0.6017 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8660 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8743 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8388 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8298 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8514 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7248 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8556 |
| Inhibitor | 0.8377 |
| AMES Toxicity | Non AMES toxic | 0.7386 |
| Carcinogens | Non-carcinogens | 0.8034 |
| Fish Toxicity | High FHMT | 0.9929 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9999 |
| Honey Bee Toxicity | Low HBT | 0.7004 |
| Biodegradation | Not ready biodegradable | 0.9935 |
| Acute Oral Toxicity | III | 0.4652 |
| Carcinogenicity (Three-class) | Non-required | 0.5479 |